<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        95-276-12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VARILRIX 2000 PFU -0.5ML VIAL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        VARICELLA ZOSTER VIRUS OKA STRAIN LIVE ATTENUATED
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1995.26
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        PFU
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        0
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        166.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXOSMITHKLINE (GSK)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXOSMITHKLINE (GSK)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J07BK01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>Varilrix is a vaccine for use in individuals from 12 months of age to protect them against chickenpox (varicella). In some circumstances, Varilrix can also be given to infants as from 9 months of age.</p><p>&nbsp;</p><p>Vaccination within 3 days of exposure to someone with chickenpox may help prevent chickenpox or reduce the severity of disease.</p><p><strong>&nbsp;</strong></p><p><strong>How Varilrix works </strong></p><p>When a person is vaccinated with Varilrix, the immune system (the body&#39;s natural defence system) will make antibodies to protect the person from being infected by chickenpox (varicella) virus.</p><p>Varilrix contains weakened viruses that are highly unlikely to cause chickenpox in healthy individuals.</p><p>&nbsp;</p><p>As with all vaccines, Varilrix may not fully protect all individuals who are vaccinated.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Varilrix :</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have any illness (such as blood disorders, cancer, Human Immunodeficiency Virus (HIV) infection or Acquired Immunodeficiency Syndrome (AIDS)) or take any medicine (including high dose corticosteroids) that weakens the immune system.<br />Whether you or your child receive the vaccine will depend upon level of your immune defences. See section 2 &ldquo;Warnings and precautions&rdquo;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child are allergic to any of the ingredients of this vaccine (listed in section 6). Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child are known to be allergic to neomycin (an antibiotic agent). A known contact dermatitis (skin rash when the skin is in direct contact with allergens such as neomycin) should not be a reason not to be vaccinated but talk to your doctor first.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have previously had an allergic reaction to any vaccine against varicella.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are pregnant. In addition, pregnancy should be avoided for 1 month following vaccination.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, pharmacist or nurse before you or your child receive Varilrix</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have a severe infection with a high temperature. It might be necessary to postpone the vaccination until recovery. A minor infection such as a cold should not require postponement of the vaccination but talk to your doctor first.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you or your child have a weakened immune system due to diseases (e.g. such as HIV infection) and/or treatments. You or your child should be closely monitored as the responses to the vaccines may not be sufficient to ensure a protection against the illness (see section 2 &ldquo;Do not use Varilrix&rdquo;).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have bleeding problems or bruise easily.</p><p>&nbsp;</p><p>Fainting can occur (mostly in adolescents) following, or even before, any needle injection. Therefore tell the doctor or nurse if you or your child fainted with a previous injection.</p><p>&nbsp;</p><p>Like other vaccines, Varilrix may not completely protect you or your child against catching chickenpox. However, individuals who have been vaccinated and catch chickenpox usually have a very mild disease, compared with individuals who have not been vaccinated.</p><p>&nbsp;</p><p>In rare cases the weakened virus can be passed on from a vaccinated person to others. This has usually occurred when the person vaccinated had some spots or blisters. Healthy individuals who become infected in this way usually only develop a mild rash, which is not harmful.</p><p>&nbsp;</p><p>Once vaccinated, you or your child should attempt to avoid for up to 6 weeks after vaccination, whenever possible, close association with the following individuals:</p><ul><li>individuals with a weakened immune system;</li><li>pregnant women who either have not had chickenpox or have not been vaccinated against chickenpox;</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; new-born infants of mothers who either have not had chickenpox or have not been vaccinated against chickenpox.</p><p>&nbsp;</p><p><strong>Other medicines and Varilrix</strong></p><p>Tell your doctor or pharmacist if you or your child are taking, have recently taken or might take any other vaccines and/or medicines.</p><p>&nbsp;</p><p>Tell your doctor if you or your child are due to have a skin test for possible tuberculosis. If this test is done within 6 weeks after receiving Varilrix, the result may not be reliable.</p><p><strong>&nbsp;</strong></p><p>Vaccination should be delayed for at least 3 months if you or your child have received a blood transfusion or human antibodies (immunoglobulins).</p><p>&nbsp;</p><p>The use of aspirin or other salicylates (a substance present in some medicines used to lower fever and relieve pain) should be avoided for 6 weeks following vaccination with Varilrix as this may cause a serious disease called Reye&rsquo;s Syndrome which can affect all body organs.</p><p>&nbsp;</p><p>Varilrix can be administered at the same time as other vaccines. A different injection site will be used for each vaccine.</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy and breast-feeding </strong></p><p>Varilrix should not be administered to pregnant women.</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist before the vaccination is given. Also, it is important that you do not become pregnant within one month after having the vaccine. During this time you should use an effective method of birth control to avoid pregnancy.</p><p>Inform your doctor if you are breast-feeding or if you intend to breast-feed. Your doctor will decide if you should receive Varilrix.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>Varilrix has no or negligible influence on the ability to drive and use machines. However, some of the effects mentioned under section 4 &ldquo;Possible side effects&rdquo; may temporarily affect the ability to drive or use machines.</p><p>&nbsp;</p><p><strong>Varilrix contains sorbitol and phenylalanine.</strong></p><p>This vaccine contains 6 mg of sorbitol per dose.</p><p>This vaccine contains 331 micrograms of phenylalanine per dose. Phenylalanine may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Varilrix is injected under the skin or into the muscle either in the upper arm or in the outer thigh.</p><p>&nbsp;</p><p>Individuals from 12 months of age should be administered 2 doses of Varilrix at least 6 weeks apart. The time between the first and second dose <strong>must not </strong>be less than 4 weeks.</p><p>&nbsp;</p><p>In some circumstances, the first dose of Varilrix may be administered to infants from 9 to 11 months of age. In these cases, two doses are needed and should be given at least 3 months apart.</p><p>&nbsp;</p><p>Individuals who are at risk of severe chickenpox such as those receiving treatment for cancer, may receive additional doses. The time between doses <strong>must not</strong> be less than 4 weeks.</p><p>&nbsp;</p><p>The appropriate time and number of doses will be determined by your doctor on the basis of appropriate official recommendations.</p><p>&nbsp;</p><p><strong>If you or your child receive more Varilrix than you or your child should</strong></p><p>Overdose is very unlikely because the vaccine is provided in a single dose vial and is administered by a doctor or nurse. Few cases of accidental administration were reported and only in some of them abnormal drowsiness and fits (seizures) were reported.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>If you think you or your child have missed a dose of Varilrix</strong></p><p>Contact your doctor who will decide if a dose is required and when to give it.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>The following side effects may happen with this vaccine</p><p><strong>&nbsp;</strong></p><p><strong>Very common</strong> (may affect more than 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain and redness at the injection site</p><p>&nbsp;</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash (spots and/or blisters)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling at the injection site*</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever of 38&deg;C or higher (rectal)*</p><p>&nbsp;</p><p><strong>Uncommon</strong> (may affect up to 1 in 100 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; upper respiratory tract infection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sore throat and discomfort when swallowing (pharingitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swollen lymph glands</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irritability</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling drowsy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cough</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, runny or blocked nose, sneezing (rhinitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nausea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chickenpox-like rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; joint pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever higher than 39.5&deg;C (rectal)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lack of energy (fatigue)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; generally feeling unwell</p><p><strong>&nbsp;</strong></p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of eye (conjunctivitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomach pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, bumpy rash (hives)</p><p>&nbsp;</p><p>*&nbsp;&nbsp;&nbsp;&nbsp; Swelling at the injection site and fever may happen very commonly in adolescents and adults. Swelling may also happen very commonly after the second dose in children under 13 years of age.</p><p>&nbsp;</p><p>The following side effects have been reported on a few occasions during routine use of Varilrix:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shingles (herpes zoster).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; small spotted bleeding or bruising more easily than normal due to a drop in a type of blood cells called platelets.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions. Rashes that may be itchy or blistering, swelling of the eyes and face, difficulty in breathing or swallowing, a sudden drop in blood pressure and loss of consciousness. Such reactions may occur before leaving the doctor&rsquo;s surgery. However, if you or your child get any of these symptoms you should contact a doctor urgently.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infection or inflammation of the brain, spinal cord and peripheral nerves resulting in temporary difficulty when walking (unsteadiness) and/or temporary loss of control of bodily movements, stroke (damage to the brain caused by an interruption to its blood supply).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits or seizures.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation, narrowing or blockage of blood vessels. This may include unusual bleeding or bruising under the skin (Henoch Schonlein purpura) or fever which lasts for more than five days, associated with a rash on the trunk sometimes followed by a peeling of the skin on the hands and fingers, red eyes, lips, throat and tongue (Kawasaki disease).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; erythema multiforme (symptoms are red, often itchy spots, similar to the rash of measles, which starts on the limbs and sometimes on the face and the rest of the body).</p><p>&nbsp;</p><p>If any of the side effects get serious, or you notice any side effects not listed in this leaflet, tell your doctor or pharmacist.</p><p><strong>&nbsp;</strong></p><p><strong>To report any side effect(s):</strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-</strong><strong>National Pharmacovigilance centre (NPC)</strong></p><ul><li>Fax: +966-11-205-7662</li><li>Reporting Hotline: 19999</li><li>Email: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa</li></ul><p><strong>-GlaxoSmithKline - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: <u>s</u>audi.safety@gsk.com<u>&nbsp; </u></li><li>Website: https://gskpro.com/en-sa/<u> </u></li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul><p>&nbsp;</p><p>For any information about this medicinal product, please contact:</p><p>GlaxoSmithKline - Head Office, Jeddah</p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>Website: https://gskpro.com/en-sa/</li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this vaccine out of the sight and reach of children.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this vaccine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store and transport refrigerated (2&deg;C - 8&deg;C).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store in the original package in order to protect from light.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After reconstitution, the vaccine should be administered promptly.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If this is not possible, the reconsistuted vaccine may be kept for up to 90 minutes at room temperature (25&deg;C) or up to 8 hours in the refrigerator (2&deg;C to 8&deg;C). If not used within the recommended in-use storage timeframes and conditions, the reconstituted vaccine must be discarded.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Varilrix contains</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is varicella live attenuated virus (Oka strain, produced in MRC-5 human diploid cells). Each 0.5 mL dose of the reconstituted vaccine contains not less than 103.3 PFU (Plaque-forming units) of varicella virus.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are:</p><p>Powder: amino acids (containing phenylalanine), lactose anhydrous, sorbitol (E 420), mannitol (E 421).</p><p>Solvent: water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Varilrix is presented as a powder and solvent for solution for injection (powder in a vial for 1 dose and solvent in a pre-filled syringe (0.5 mL)) with or without separate needles in the following pack sizes:
•	with 1 separate needle: pack sizes of 1 or 10.
with 2 separate needles: pack sizes of 1 or 10.
•	without needles: pack sizes of 1 or 10.

Varilrix is supplied as slightly cream to yellowish or pinkish powder and a clear colourless solvent (water for injections) for reconstituting the vaccine.

Not all listed packs are marketed.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by: </strong></p><p>GlaxoSmithKline BiologicalsS.A..</p><p>89, rue de l&rsquo;Institut -B-1330 Rixensart</p><p>Belgium Tel: (32) 2 656 81 11 Fax: (32) 2 656 80 00</p><p>&nbsp;</p><p><strong>Packed by: </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia</p><p>*member of the GlaxoSmithKline group of companies</p><p><strong>&nbsp;</strong></p><p><strong>Marketing Authorization holder: </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia</p><p>*member of the GlaxoSmithKline group of companies</p><p>&nbsp;</p><p><strong>Varilrix</strong> is a trademark are owned by or licensed to the GSK group of companies</p><p>&copy; 2022 GSK group of companies or its licensor</p><p>&nbsp;</p><p><strong>The following information is intended healthcare professionals only.</strong></p><p><strong>&nbsp;</strong></p><p>Varilrix<!--[if supportFields]><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Arial'><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_7f5b0266-aea2-463d-b690-4694bdfcc9f5
\* MERGEFORMAT <span style='mso-element:field-separator'></span></span></sup><![endif]--><sup>&nbsp;</sup><!--[if supportFields]><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Arial'><span style='mso-element:
field-end'></span></span></sup><![endif]--></p><p>10<sup>3.3</sup> PFU/0.5 ml, powder and solvent for solution for injection.</p><p><strong>&nbsp;</strong></p><p>As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.</p><p>&nbsp;</p><p>Alcohol and other disinfecting agents must be allowed to evaporate from the skin before injection of the vaccine since they can inactivate the attenuated viruses in the vaccine.</p><p>&nbsp;</p><p>Varilrix must not be administered intravascularly or intradermally.</p><p><strong>&nbsp;</strong></p><p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p><p>&nbsp;</p><p>The solvent and the reconstituted vaccine should be inspected visually for any foreign particulate matter and/or abnormal physical appearance before administration. In the event of either being observed, do not administer the vaccine.</p><p><img alt="" width="569" height="452" src="data:image/png;base64,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" /></p><p>Always hold the syringe by the barrel, not by the syringe plunger or the Luer Lock Adaptor (LLA), and maintain the needle in the axis of the syringe (as illustrated in picture 2). Failure to do this may cause the LLA to become distorted and leak.</p><p>During assembly of the syringe, if the LLA comes off, a new vaccine dose (new syringe and vial) should be used.</p><p>&nbsp;</p><p>1. Unscrew the syringe cap by twisting it anticlockwise (as illustrated in picture 1).</p><p>Whether the LLA is rotating or not, please follow below steps:</p><p>&nbsp;</p><p>2. Attach the needle to the syringe by gently connecting the needle hub into the LLA and rotate a quarter turn clockwise until you feel it lock (as illustrated in picture 2).</p><p>&nbsp;</p><p>3. Remove the needle protector, which may be stiff.</p><p>&nbsp;</p><p>4. Add the solvent to the powder.The mixture should be well shaken until the powder is completely dissolved in the solvent .</p><p>The colour of the reconstituted vaccine may vary from clear peach to pink due to minor variations of its pH. This is normal and does not impair the performance of the vaccine. In the event of other variation being observed, do not administer the vaccine.</p><p>5. Withdraw the entire contents of the vial.</p><p>&nbsp;</p><p>6. A new needle should be used to administer the vaccine. Unscrew the needle from the syringe and attach the injection needle by repeating step 2 above.</p><p>&nbsp;After reconstitution, it is recommended that the vaccine be injected as soon as possible.</p><p>However, it has been demonstrated that the reconstituted vaccine may be kept for up to 90 minutes at room temperature (25&deg;C) and up to 8 hours in the refrigerator (2&deg;C to 8&deg;C). If not used within the recommended in-use storage timeframes and conditions, the reconstituted vaccine must be discarded.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:roundrect id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_20"
 o:spid="_x0000_s1026" style='position:absolute;margin-left:-11.25pt;
 margin-top:10.7pt;width:494.25pt;height:177pt;z-index:-251636736;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:middle'
 arcsize="2661f" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" fillcolor="white [3201]" strokecolor="#0d0d0d [3069]" strokeweight="1.5pt">
 <v:stroke joinstyle="miter"/>
</v:roundrect><![endif]--><img width="661" height="239" src="file:///C:/Users/mh360004/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png" /></p><p>&nbsp;</p><p><strong>THIS IS A MEDICAMENT</strong></p><p>&nbsp;</p><p>- Medicament is a product which affects your health, and its consumption contrary to</p><p>&nbsp;&nbsp; instructions is dangerous for you.</p><p>- Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the&nbsp;&nbsp;</p><p>&nbsp;&nbsp; pharmacist who sold the medicament.</p><p>- The doctor and the pharmacist are experts in medicine, its benefits and risks.</p><p>- Do not by yourself interrupt the period of treatment prescribed for you.</p><p>- Do not repeat the same prescription without consulting your doctor.</p><p>- Keep all medicine out of reach of children.</p><p>Council of Arab Health Ministers</p><p>Union of Arab Pharmacists</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: UK issue 9 draft 2
Date of issue:  15 October 2021

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">فاريلركس هو لقاح يُعطى للاشخاص من عمر12 أشهر لحمايتهم من جدرى الماء أو &quot;الحماق&quot;. كما يمكن اعطاءه للرضع بدءًا من عمر 9 أشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">التطعيم خلال 3 ايام من التعرض لمصاب بالجدرى الماء قد يساعد على عدم الاصابة بالجدرى الماء او التقليل من حدة المرض.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>آلية عمل لقاح فاريلركس </strong></p><p dir="RTL">في حال تلقى شخص لقاح فاريليريكس، فإن الجهاز المناعي (نظام الدفاع الطبيعي للجسم) يُنتج أجسامًا مضادة لحماية الشخص من الإصابة بفيروس جدري الماء (الحماق).</p><p dir="RTL">يحتوي فاريليريكس على فيروسات مُضعّفة من غير المحتمل أن تصيب الأشخاص الأصحاء بعدوى الجدري المائي.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">كما هو الحال في بقية اللقاحات، قد لا يحمي فاريليريكس بشكل كامل جميع الأشخاص الذين حصلوا على اللقاح.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب الامتناع عن التطعيم بلقاح فاريلركس في الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أنت أو طفلك من أي مرض (مثل أمراض الدم، السرطان، عدوى فيروس نقص المناعة البشرية (الأيدز)، أو تتناول أي علاج (بما في ذلك الكورتيكوستيرويدات) قد يُضعف الجهاز المناعي.<br />يعتمد حصولك أنت أو طفلك على اللقاح على مستوى دفاعاتك المناعية.<strong> </strong>أنظر القسم 2 &quot;التحذيرات والتدابير الوقائية&quot;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني انت أو طفلك من الحساسية تجاه أي من مكونات هذا اللقاح. (المدرجة في القسم 6).<strong> </strong>قد تشمل علامات رد الفعل التحسسي طفح جلدي وحكة وضيق في التنفس وتورم في الوجه أو اللسان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أنت أو طفلك من حساسية تجاه نيومايسين (فئة المضادات الحيوية).<strong> </strong>لا ينبغي أن يكون التهاب الجلد التماسي المعروف (طفح جلدي عندما يكون الجلد على اتصال مباشر مع مسببات الحساسية مثل نيومايسين) سببًا لعدم تلقي اللقاح ولكن تحدث إلى طبيبك أولاً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بارتفاع في درجة الحرارة (حمى) إذا كنت تعاني أنت أو طفلك من حساسية تجاه اى لقاح ضد الحماق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ حاملاً. علاوة على ذلك، ينبغي تجنُّب الحمل لمدة شهر واحد عقب التطعيم باللقاح.</p><p dir="RTL">.</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">استشر الطبيب، او الصيدلي أو الممرضة قبل تناولك أنت أو طفلك ا اللقاح:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حال كنت تعاني أنت أو طفلك من عدوي شديدة مصحوبة بارتفاع درجة الحرارة. قد يكون من الضروري تأجيل تلقي اللقاح لحين تمام الشفاء. لا داعي لتأجيل تلقي اللقاح بسبب العدوى البسيطة مثل البرد، ولكن تحدث إلى طبيبك أولاً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أنت أو طفلك من ضعف في جهاز المناعة بسبب أمراض (مثل عدوى فيروس نقص المناعة البشرية) و/ أو العلاجات. يجب مراقبتك أنت أو طفلك عن كثب لأن الاستجابات للقاحات قد لا تكون كافية لضمان الحماية من المرض (انظر القسم 2 &quot;لا تستخدم فاريليريكس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حدوث نزيف أو كدمات بسهولة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يحدث إغماء (بين المراهقين في معظم الأحيان) بعد أي عملية حقن بإبرة أو حتى قبل الحقن بها. وبالتالي يجب إبلاغ الطبيب أو الممرضة إذا كنت قد أُصبت بالإغماء أو أصيب طفلك بالإغماء عند حقنه في السابق.</p><p dir="RTL">&nbsp;</p><p dir="RTL">مثل اللقاحات الأخرى، قد لا يحميك فاريليريكس تمامًا أنت أو طفلك من الإصابة بالجدري المائي. ومع ذلك، فإن الأفراد الذين حصلوا على اللقاح وأصيبوا بجدري الماء عادة ما يكون لديهم مرض طفيف للغاية، مقارنةً بالأفراد الذين لم يتم تطعيمهم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالات نادرة، قد ينتقل الفيروس المُضعف من الشخص المُلقح إلى الآخرين. يحدث هذا عادة عندما يكون لدى الشخص الذي تلقى اللقاح بعض البقع أو البثور. عادة ما يعاني الأفراد الأصحاء الذين يصابون بهذه الطريقة من طفح جلدي خفيف، وهو غير ضار.</p><p dir="RTL">&nbsp;</p><p dir="RTL">بمجرد تلقي اللقاح، يجب أن تحاول أنت أو طفلك تجنب الارتباط الوثيق بالأفراد التاليين لمدة تصل إلى 6 أسابيع بعد التطعيم، كلما أمكن ذلك:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأفراد الذين يعانون من ضعف في جهاز المناعة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النساء الحوامل اللواتي لم يصبن بجدري الماء أو لم يتم تطعيمهن ضد جدري الماء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حديثى الولادة لامهات اللواتي لم يصبن بجدري الماء أو لم يتم تطعيمهن ضد جدري الماء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى ولقاح فاريلركس</strong></p><p dir="RTL">أخبر طبيبك إذا كنت أنت أو طفلك تتناولون أى لقاحات/أو أدوية أخرى أو على وشك تناولها أو سبق تناولها مؤخرًا.</p><p dir="RTL">أخبر طبيبك إذا كنت أنت أو طفلك ستخضعان لاختبار جلدي لاحتمال الإصابة بالسل.<strong> </strong>إذا تم إجراء هذا الاختبار في غضون 6 أسابيع بعد تلقي فاريليريكس، فقد لا تكون النتيجة موثوقة.</p><p dir="RTL">يجب تأجيل التطعيم لمدة 3 أشهر على الأقل إذا تلقيت أنت أو طفلك نقل دم أو أجسامًا مضادة بشرية (جلوبيولين مناعي).</p><p dir="RTL">يجب تجنب استخدام الأسبرين أو الساليسيلات الأخرى (مادة موجودة في بعض الأدوية المستخدمة لخفض الحمى وتسكين الألم) لمدة 6 أسابيع بعد التطعيم مع فاريليريكس لأن هذا قد يسبب مرضًا خطيرًا يسمى متلازمة راي والذي يمكن أن يؤثر على جميع أعضاء الجسم.</p><p dir="RTL">يمكن إعطاء لقاح فاريلركس بالتزامن مع اللقاحات الأخرى. يجب حقن كل لقاح على حدة فى مكان حقن مختلف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية </strong></p><p dir="RTL">لا يجب اعطاء الفاريلركس للسيدات الحوامل.</p><p dir="RTL">إذا كنتِ حاملاً أو ترضعين رضاعةً طبيعية، أو تعتقدين أنكِ ربما تكونين حاملاً أو تخططين للإنجاب، يجب استشارة الطبيب قبل التطعيم باللقاح. ومن المهم أيضًا تجنّب الحمل بعد التطعيم باللقاح بمدة شهر. وينبغي في أثناء هذه الفترة استخدام وسيلة فعَّالة لتحديد النسل لتجنُّب الحمل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أبلغى طبيبك اذا كنت ترضعين رضاعة طبيعية أو تنتوين ارضاع طفلك رضاعة طبيعية. طبيبك هو الذى يقرر أذا كان يمكنك تلقي لقاح فاريلركس.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">لا يؤثر فاريليريكس أو له تأثير لا يُذكر على القيادة واستخدام الآلات. ومع ذلك، فإن بعض الآثار المذكورة في القسم 4 &quot;الآثار الجانبية المحتملة&quot; قد تؤثر مؤقتًا على القدرة على القيادة أو استخدام الآلات</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">.</p><p dir="RTL"><strong>احتواء لقاح فاريلركس على السوربيتول</strong> <strong>و الفينيل الأنين</strong>.</p><p dir="RTL">يحتوي هذا اللقاح &nbsp;على 6 ملجم من السوربيتول لكل جرعة.</p><p dir="RTL">يحتوي هذا اللقاح 331 ميكروجم من الفينيل الأنين لكل جرعة. قد يكون الفينيل الأنين مؤذى اذا كنت تعانى من ِبيَلةُ (مرض) الفينيل كيتون (PKU),هو مرض وراثى نادر بسبب تراكم الفينيل الأنين لعدم قدرة الجسم التخلص منه بشكل سليم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL">يحقن لقاح فاريلركس في صورة حقنة تحت الجلد، إما في الجزء العلوي من الذراع أو في الجزء الخارجي من الفخذ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأشخاص من عمر 12 أشهر يجب إعطاءهم جرعتين من لقاح فاريلركس بينهم فاصل زمني 6 اسابيع. الفصل بين الجرعتين الأولى والثانية بفترة زمنية <strong>يجب ألا تقل</strong> بأي حال من الأحوال عن 4 أسابيع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في بعض الحالات، يمكن إعطاء الجرعة الأولى من فاريليريكس للرضع من عمر 9 إلى 11 شهرًا.<strong> </strong>في هذه الحالات، هناك حاجة لإعطاء جرعتين ويجب أن تعطى كل منها على الأقل 3 أشهر على حدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يحصل الأفراد المعرضون لخطر الإصابة بجدري الماء الشديد مثل أولئك الذين يتلقون علاجًا للسرطان جرعات إضافية.<strong> </strong><strong>يجب ألا تقل</strong> الفترة الزمنية بين الجرعات عن 4 أسابيع.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">سيحدد طبيبك الوقت المناسب وعدد الجرعات على أساس التوصيات الرسمية المناسبة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تلقيت أنت أو طفلك فاريلريكس أكثر مما ينبغي لك أو لطفلك</strong></p><p dir="RTL">من غير المرجح إلى حد كبير إعطاء جرعة زائدة لأن اللقاح يتم توفيره في زجاجة جرعة واحدة ويتم إعطاؤه بواسطة طبيب أو ممرضة. أُبلغ عن حالات قليلة من الإعطاء العرضي وفي بعضها فقط تم الإبلاغ عن نعاس غير طبيعي ونوبات (تشنجات).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا</strong><strong> كنت تظن أنت او طفلك قد فاتته جرعة من لقاح فاريلركس</strong></p><p dir="RTL">اتصل بطبيبك الذى سيقرر إذا كانت الجرعة مطلوبة و متى يجب إعطاءها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يمكن أن يسبب لقاح فاريلركس، مثل كل اللقاحات، آثارًا جانبية؛ إلا أن تلك الآثار لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية التالية الممكن حدوثها مع هذا اللقاح</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة جدًا</strong> ( قد تؤثر في أكثر من شخصٍ واحد من بين كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الألم و الاحمرار موضع الحقن</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار شائعة</strong> (قد تؤثر في شخصٍ واحد من بين كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي (بقع و/أو بثور).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم موضع الحقن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; حمى 38 درجة مئوية أو أعلى (المستقيم) *</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار غير شائعة</strong> (قد تؤثر في شخصٍ واحد من بين كل 100 شخص)</p><p dir="RTL">&middot;&nbsp; عدوى الجهاز التنفسى العلوى</p><p dir="RTL">&middot;&nbsp; صعوبة عند البلع (التهاب الحلق).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورُّم الغدد الليمفاوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سرعة الانفعال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالنعاس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السعال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة ،رشح الأنف أو العطس ،وانسداد الأنف (التهاب الأنف)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الغثيان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مثل الجدرى الماء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في المفاصل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم فى العضلات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;حمى 38 درجة مئوية أو أعلى (المستقيم) *</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض الطاقة (الإرهاق)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور عام بعدم الراحة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار نادرة</strong> (قد تؤثر في شخصٍ واحد من بين كل 1000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب العينين (التهاب الملتحمة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في المعدة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي بارز(الشرى)</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; * قد يحدث التورم في موضع الحقن والإصابة بالحمى بشكل شائع جدًا لدى المراهقين والبالغين. قد يحدث التورم أيضًا بشكل شائع بعد الجرعة الثانية عند الأطفال دون سن 13 عامًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم الإبلاغ عن الآثار الجانبية التالية في حالات قليلة أثناء الاستخدام الروتيني لـفاريليريكس:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (جدري المائي النطاقي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف طفيف متقطع أو كدمات تحدث بسهولة عن المعتاد بسبب انخفاض نوع من خلايا الدم يسمى الصفائح الدموية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التفاعلات التحسسية. طفح جلدي قد يكون حكة أو بثور، انتفاخ في العينين والوجه، صعوبة في التنفس أو البلع، انخفاض مفاجئ في ضغط الدم وفقدان الوعي. قد تحدث مثل هذه التفاعلات قبل مغادرة عيادة الطبيب. ومع ذلك، إذا أصبت أنت أو طفلك بأي من هذه الأعراض، يجب عليك الاتصال بالطبيب على وجه السرعة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى أو التهاب في الدماغ والحبل الشوكي والأعصاب الطرفية مما يؤدي إلى صعوبة مؤقتة في المشي (الاهتزاز) و/ أو فقدان مؤقت للسيطرة على حركات الجسم، والسكتة الدماغية (تلف الدماغ الناجم عن انقطاع إمدادات الدم).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات أو تشنجات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب، أو تضيق أو انسداد الأوعية الدموية. قد يشمل ذلك نزيفًا غير عادي أو كدمات تحت الجلد (فرفرية هينوخ شونلاين) أو حمى تستمر لأكثر من خمسة أيام، مصحوبة بطفح جلدي على الجذع يتبعه أحيانًا تقشر الجلد في اليدين والأصابع واحمرار العينين والشفتين والحنجرة واللسان (مرض كاواساكي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى متعددة الأشكال (الأعراض تكون، بقع حمراء مصحوبة بحكة، تشبه طفح الحصبة الذي يبدأ على الأطراف وأحيانًا على الوجه وبقية الجسم).</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حال تفاقم أي من الآثار الجانبية أو ملاحظة ظهور آثار جانبية غير مذكورة في هذه النشرة، أبلغ الطبيب أو الصيدلاني.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن أي آثار جانبية:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- المركز الوطني للتيقظ والسلامة الدوائية </strong><strong>(NPC)</strong></p><ul><li dir="RTL">فاكس: 7662-205-11-966+</li><li dir="RTL">الاتصال بالرقم الموحد: 19999</li><li dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</li><li dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa</li></ul><p dir="RTL"><strong>- </strong><strong>- GlaxoSmithKline</strong><strong> المقر الرئيسي، جدة</strong></p><ul><li dir="RTL">هاتف: 6536666-12-966+</li><li dir="RTL">جوال: 9882-904-56-966+</li><li dir="RTL">البريد الإلكتروني: <u>s</u>audi.safety@gsk.com</li></ul><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://gskpro.com/en-sa/</p><ul><li dir="RTL">ص. ب. رقم 55850، جدة 21544، المملكة العربية السعودية</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإستفسار عن أي معلومات عن هذا المستحضر الدوائي، يرجى الإتصال بالأرقام التالية:</strong></p><p dir="RTL">جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666-12-966+</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوال: -56-904-9882966+</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: gcc.medinfo@gsk.com</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://gskpro.com/en-sa/</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب. 55850، جدة 21544، المملكة العربية السعودية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفظ بعيدًا عن مرأى ومتناول الأطفال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم استخدام لقاح فاريلركس بعد تاريخ انتهاء الصلاحية المدوَّن على الملصق والعبوة الكرتونية تاريخ انتهاء الصلاحية هو اخر يوم فى الشهر المدون.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ و ينقل فى الثلاجة في درجة حرارة بين 2 و8 درجات مئوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ الدواء في العبوة الأصلية لجمايته من الضوء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وينبغي حقن اللقاح بعد تحضيره على الفور</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ان لم يكن هذا ممكنا ، يحفظ اللقاح المستنشأ لمدة تصل ل90 دقيقة فى درجة حرارة الغرفة (25 درجة مئوية) و لمدة تصل ل8 ساعات في الثلاجة (2 درجة مئوية-8 درجة مئوية). إذا لم يتم استخدامه خلال الفترة الزمنية الموصى بها و شروط التخزين الخاصة، يجب التخلص من اللقاح المستنشأ</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من الأدوية برميها في مياه الصرف أو ضمن المخلفات المنزلية. استشر الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستعملها. فهذه الإجراءات من شأنها أن تحافظ على البيئة</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مكونات لقاح فاريلركس</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكوّن الفعال للقاح هو الفيروس &quot;النطاقي الحماقي&quot; الحي والضعيف (والمعروف أيضًا باسم فيروس السلالة)، ويتم تحضيره في خلايا MRC<sub>5</sub> ثنائية الصبغة البشرية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحتوي كل جرعة مكوَّنة من 0,5 ملليلتر على أقل من <sup>3</sup>10&rsquo;<sup>3</sup> من وحدات تشكيل الصفائح (PFU) من هذا الفيروس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشمل المكونات الأخرى الأحماض الأمينية واللاكتوز والمانيتول والسوربيتول.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شكل لقاح فاريلركس ومحتويات العبوة</strong></p><p dir="RTL">لقاح فاريلركس عبارة عن حبة صغيرة أو مسحوق لونهما أبيض مائل للأصفر أو وردي اللون في قنينات بسعة 3 ملليلترات. وتحتوي العبوة أيضًا على أمبولة زجاجية منفصلة بسعة 1 ملليلتر، أو محقنة معبأة مسبقًا تحتوى على سائل معقَّم عديم اللون<br />(ماء للحقن). فور الانتهاء من التحضير، يتحول لقاح فاريلركس إلى محلول تكون درجة لونه بين لون الخوخ الصاف والوردي. ويتوفر اللقاح في عبوات تحتوي على محقنة واحدة.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">لا يتم تسويق بعض العبوات المذكورة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة المصنعة: </strong></p><p dir="RTL">GlaxoSmithKline Biologicals s.a.</p><p dir="RTL">89, rue de l&rsquo;Institut - 1330 Rixensart</p><p dir="RTL">هاتف بلجيكا: 11 81 656 2 (32) فاكس: 00 80 656 2 (32) &nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تمت التعبئة بواسطة: </strong></p><p dir="RTL">Glaxo Saudi Arabia Ltd.* جدة، المملكة العربية السعودية</p><p dir="RTL">العنوان: ص. ب. رقم 22617 جدة 21416 &ndash; المملكة العربية السعودية</p><p dir="RTL">*إحدى شركات GlaxoSmithKline</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>مالك التسويق المعتمد: </strong></p><p dir="RTL">Glaxo Saudi Arabia Ltd.* جدة، المملكة العربية السعودية</p><p dir="RTL">العنوان: ص. ب. رقم 22617 جدة 21416 &ndash; المملكة العربية السعودية</p><p dir="RTL">*إحدى شركات GlaxoSmithKline</p><p dir="RTL">&nbsp;</p><p dir="RTL">فاريلركس علامة تجارية مملوكة أو مرخصة لمجموعة شركات GSK</p><p dir="RTL">حقوق النشر &copy; لعام 2022محفوظة لمجموعة شركات GSK أو مانح التراخيص الخاص بها</p><p dir="RTL">&nbsp;</p><p dir="RTL">----------------------------------------------------------------------------------------------------------------</p><p dir="RTL"><strong>تعليمات الاستخدام</strong></p><p dir="RTL"><strong>المعلومات التالية خاصة باختصاصيي الرعاية الصحية فحسب.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>فاريلركس ،</strong>مسحوق ومذيب لمحلول الحقن.</p><p dir="RTL">لقاح الحماق (الحى )</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&nbsp;كما هو الحال في بقية اللقاحات (الحقن)، يجب وجود العلاج و الاشراف الطبى المستمرفى حالة الصدمة التحسسية نادرة الحدوث بعد تلقى لقاح فاريلركس.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب الانتظار لحين تبخُّر الكحوليات وغيرها من المواد المطهِّرة من البشرة قبل حقن اللقاح؛ فربما توقِف نشاط الفيروس.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا ينبغي أن يُعطى فاريلريكس داخل الأوعية الدموية أو داخل الجلد.</p><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong>آلا يجب مزج هذا المستحضر الدوائى مع مستحضرات الدوائية الأخرى فى ظل غياب الدراسات الطبية للتوافق.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي فحص المذيب واللقاح المستنشأ بالنظر للتأكد من عدم وجود أي جسيمات غريبة و/أو تغيُّر في الشكل المادي قبل التحضير أو الاستعمال. في حالة ملاحظة أي من هذين الأمرين، لا تستخدم من مادة التخفيف أو اللقاح المستنشأ.</p><p><img alt="" width="613" height="478" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p dir="RTL">احمل دائمًا السرنجة من أنبوب المحقنة، وليس من مكبس المحقنة أو المحبس، وحافظ على الإبرة في محور أنبوب المحقنة (كما هو موضح في الصورة 2). قد يؤدي عدم اتباع هذه التعليمات إلى تشوه المحبس أو تسرب الدواء منه</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا خُلِعَ المحبس أثناء تجميع السرنجة، فيتعين استخدام لقاح جديد (سرنجة وقارورة جديدتان)</p><p dir="RTL">&nbsp;</p><p dir="RTL">1.قم بفك غطاء المحقنة عن طريق لفه عكس اتجاه عقارب الساعة (كما هو موضح في الصورة 1). يُرجى اتباع الخطوات التالية، بغض النظر عما إذا كان المحبس يدور أم لا:</p><p dir="RTL">&nbsp;</p><p dir="RTL">2. قم بتوصيل الإبرة بالسرنجة عن طريق توصيل محور الإبرة بلطف بالمحبس وقم بالتدوير ربع دورة في اتجاه عقارب الساعة حتى تشعر بها تُغلَق بإحكام (كما هو موضح في الصورة 2).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;3. قم بإزالة واقي الإبرة، والذي قد يكون صلبًا</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;4. أضِف مادة التخفيف إلى المسحوق. بعد إضافة مادة التخفيف إلى المسحوق، ينبغي رجّ المزيج جيدًا حتى يذوب المسحوق<br />بالكامل في مادة التخفيف.</p><p dir="RTL">وينبغي حقن اللقاح بعد تحضيره على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">5. اسحب كامل محتويات القنينة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">6. يتعين استخدام إبرة جديدة لإعطاء اللقاح.قم بفك الإبرة من السرنجة وقم بتوصيل إبرة الحقن بتكرار الخطوة 2 أعلاه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب الانتظار لحين تبخُّر الكحوليات وغيرها من المواد المطهِّرة من البشرة قبل حقن اللقاح؛ فربما توقِف نشاط الفيروس.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي التخلّص من أي منتج غير مستعمل أو مخلفات دوائية وفق الشروط المحلية.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
رقم الإصدار: UK issue 9 draft 2
تاريخ الإصدار: 15 أكتوبر 2021

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Varilrix powder and solvent for solution for injection in pre-filled syringe
Varicella vaccine (live)

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                After reconstitution, one dose (0.5 mL) contains:
Varicella virus1 Oka strain (live, attenuated) not less than 103.3 PFU2
1 produced in human diploid cells (MRC-5)
2 plaque forming units
This vaccine contains a trace amount of neomycin (see section 4.3).
Excipients with known effect:
The vaccine contains 6 mg of sorbitol per dose.
The vaccine contains 331 micrograms of phenylalanine per dose (see section 4.4).
For the full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder and solvent for solution for injection in pre-filled syringe.
Before reconstitution, the powder is slightly cream to yellowish or pinkish coloured 
cake and the solvent is a clear colourless liquid
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Varilrix is indicated for active immunisation against varicella - In healthy individuals from 9 to 11 months of age (see section 5.1), under special circumstances; - In healthy individuals from the age of 12 months (see section 5.1); - For post-exposure prophylaxis if administered to healthy, susceptible individuals exposed to varicella within 72 hours of contact (see sections 4.4 and 5.1) - In individuals at high risk of severe varicella (see sections 4.3, 4.4 and 5.1). The use of Varilrix should be based on official recommendations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology The immunisation schedules for Varilrix should be based on official recommendations. Healthy individuals Infants from 9 months to 11 months of age (inclusive) Infants from 9 to 11 months of age (inclusive) receive two doses of Varilrix to ensure optimal protection against varicella (see section 5.1). The second dose should be given after a minimum interval of 3 months. Children from 12 months of age, adolescents and adults Children from the age of 12 months as well as adolescents and adults receive two doses of Varilrix to ensure optimal protection against varicella (see section 5.1). The second dose should generally be given at least 6 weeks after the first dose. Under no circumstances should the interval between the doses be less than 4 weeks. Individuals at high risk of severe varicella Individuals at high risk of severe varicella may benefit from re-vaccination following the 2-dose schedule (see section 5.1). Periodic measurement of varicella antibodies after immunisation may be indicated in order to identify those who may benefit from re-immunisation. Under no circumstances should the interval between the doses be less than 4 weeks. Other paediatric population The safety and efficacy of Varilrix in infants less than 9 months of age have not yet been established. No data are available Interchangeability - A single dose of Varilrix may be administered to those who have already received a single dose of another varicella-containing vaccine. - A single dose of Varilrix may be administered followed by a single dose of another varicella-containing vaccine. GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics&nbsp; Method of administration Varilrix is to be injected subcutaneously (SC) or Intramuscularly (IM) in the deltoid region or in the anterolateral area of the thigh. Varilrix should be administered subcutaneously in individuals with bleeding disorders (e.g. thrombocytopenia or any coagulation disorder). For instructions on reconstitution of the medicinal product before administration, see section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Varilrix is contraindicated in individuals with severe humoral or cellular (primary or 
acquired) immunodeficiency such as (see also section 4.4.):
- subjects with immunodeficiency states with a total lymphocyte count less than 
1,200 per mm3;
- subjects presenting other evidence of lack of cellular immune competence 
(e.g. patients with leukaemias, lymphomas, blood dyscrasias, clinically 
manifest HIV infection);
- subjects receiving immunosuppressive therapy including high dose of 
corticosteroids;
- severe combined immunodeficiency;
- agammaglobulinemia;
- AIDS or symptomatic HIV infection or an age-specific CD4+ T-lymphocyte 
percentage in children below 12 months: CD4+ <25%; children between 12-
35 months: CD4+ < 20%; children between 36-59 months: CD4+ < 15%.
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 
or to neomycin. However, a history of contact dermatitis to neomycin, is not a 
contraindication.
Varilrix is contraindicated in subjects having shown signs of hypersensitivity after 
previous administration of varicella vaccine. 
Pregnancy. Furthermore, pregnancy should be avoided for 1 month following 
vaccination (see section 4.6).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Traceability In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded. As with other vaccines, the administration of Varilrix should be postponed in subjects suffering from acute severe febrile illness. However, the presence of a minor infection, such as a cold, should not result in the deferral of vaccination. GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics&nbsp; Syncope (fainting) can occur following, or even before, any vaccination especially in adolescents as a psychogenic response to the needle injection. This can be accompanied by several neurological signs such as transient visual disturbance, paraesthesia and tonic-clonic limb movements during recovery. It is important that procedures are in place to avoid injury from faints. As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic reaction following the administration of the vaccine. Alcohol and other disinfecting agents must be allowed to evaporate from the skin before injection of the vaccine since they can inactivate the attenuated viruses in the vaccine. Limited protection against varicella may be obtained by vaccination up to 72 hours after exposure to natural disease (see section 5.1). As with any vaccine, a protective immune response may not be elicited in all vaccinees. As for other varicella vaccines, cases of varicella disease have been shown to occur in persons who have previously received Varilrix. These breakthrough cases are usually mild, with a fewer number of lesions and less fever as compared to cases in unvaccinated individuals. Transmission Transmission of the Oka varicella vaccine virus has been shown to occur at a very low rate in seronegative contacts of vaccinees with rash. Transmission of the Oka varicella vaccine virus from a vaccinee who does not develop a rash to seronegative contacts cannot be excluded. Compared to healthy vaccinees, leukaemia patients are more likely to develop a papulovesicular rash (see also section 4.8). In these cases too, the course of the disease in the contacts was mild. Vaccine recipients, even those who do not develop a varicella-like rash, should attempt to avoid contact, whenever possible, with high-risk individuals susceptible to varicella for up to 6 weeks following vaccination. In circumstances where contact with high-risk individuals susceptible to varicella is unavoidable, the potential risk of transmission of the varicella vaccine virus should be weighed against the risk of acquiring and transmitting wild-type varicella virus. High-risk individuals susceptible to varicella include: - Immunocompromised individuals (see sections 4.3 and 4.4); - Pregnant women without documented positive history of varicella GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics (chickenpox) or laboratory evidence of prior infection; - Newborns of mothers without documented positive history of chickenpox or laboratory evidence of prior infection. The mild nature of the rash in the healthy contacts indicates that the virus remains attenuated after passage through human hosts. Individuals at high risk of severe varicella There is only limited data from clinical trials available for Varilrix (+4&deg;C formulation) in individuals at high risk of severe varicella. Vaccination may be considered in patients with selected immune deficiencies where the benefits outweigh the risks (e.g. asymptomatic HIV subjects, IgG subclass deficiencies, congenital neutropenia, chronic granulomatous disease, and complement deficiency diseases). Immunocompromised patients who have no contraindication for this vaccination (see section 4.3) may not respond as well as immunocompetent subjects, therefore some of these patients may acquire varicella in case of contact, despite appropriate vaccine administration. These patients should be monitored carefully for signs of varicella. Should vaccination be considered in individuals at high risk of severe varicella, it is advised that: - maintenance chemotherapy should be withheld one week before and one week after immunisation of patients in the acute phase of leukaemia. Patients under radiotherapy should normally not be vaccinated during the treatment phase. Generally, patients are immunised when they are in complete haematological remission from their disease. - the total lymphocyte count should be at least 1,200 per mm3 or no other evidence of lack of cellular immune competence exists. - vaccination should be carried out a few weeks before the administration of the immunosuppressive treatment for patients undergoing organ transplantation (e.g. kidney transplant). Very few reports exist on disseminated varicella with internal organ involvement following vaccination with Oka varicella vaccine strain mainly in immunocompromised subjects. Varilrix must not be administered intravascularly or intradermally. Phenylalanine content The vaccine contains 331 micrograms of phenylalanine per dose. Phenylalanine may be harmful for individuals with phenylketonuria (PKU).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p style="text-align:justify">If tuberculin testing has to be done it should be carried out before or simultaneously with vaccination since it has been reported that live viral vaccines may cause a temporary depression of tuberculin skin sensitivity. As this anergy may last up to a GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics&nbsp; maximum of 6 weeks, tuberculin testing should not be performed within that period after vaccination to avoid false negative results. In individuals who have received immunoglobulins or a blood transfusion, vaccination should be delayed for at least three months because of the likelihood of vaccine failure due to passively acquired varicella antibodies. Salicylates should be avoided for 6 weeks after varicella vaccination as Reye&rsquo;s Syndrome has been reported following the use of salicylates during natural varicella infection. Use with other vaccines Healthy individuals Clinical studies with varicella-containing vaccines support concomitant administration of Varilrix with any of the following monovalent or combination vaccines: measles-mumps-rubella vaccine (MMR), diphtheria-tetanus-acellular pertussis vaccine (DTPa), reduced antigen diphtheria-tetanus-acellular pertussis vaccine (dTpa), Haemophilus influenzae type b vaccine (Hib), inactivated polio vaccine (IPV), hepatitis B vaccine (HBV), hexavalent vaccine (DTPa-HBV-IPV/Hib), hepatitis A vaccine (HAV), meningococcal serogroup B vaccine (Bexsero), meningococcal serogroup C conjugate vaccine (MenC), meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY) and pneumococcal conjugate vaccine (PCV). Different injectable vaccines should always be administered at different injection sites. If a measles vaccine is not given at the same time as Varilrix, there should be an interval of at least one month between the administration of these vaccines as the measles vaccine may lead to short-term suppression of the cellular immune response. Individuals at high risk of severe varicella Varilrix should not be administered at the same time as other live attenuated vaccines. Inactivated vaccines may be administered in any temporal relationship to Varilrix, given that no specific contraindication has been established. However, different injectable vaccines should always be administered at different injection sites.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Pregnancy Pregnant women should not be vaccinated with Varilrix. However, foetal damage has not been documented when varicella vaccines have been given to pregnant women. Women of child-bearing potential GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics&nbsp; Pregnancy should be avoided for 1 month following vaccination. Women who intend to become pregnant should be advised to delay. Breast-feeding There are no data regarding use in breast-feeding women. Due to the theoretical risk of transmission of the vaccine viral strain from mother to infant, Varilrix is generally not recommended for breast-feeding mothers (see also section 4.4). Vaccination of exposed women with negative history of varicella or known to be seronegative to varicella should be assessed on an individual basis. Fertility No data available</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects of Varilrix on the ability to drive and use machines have been performed. Varilrix has no or negligible influence on the ability to drive and use machines. However, some of the effects mentioned under section 4.8 &ldquo;Undesirable effects&rdquo; may temporarily affect the ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Clinical trial data Healthy individuals More than 7,900 individuals have participated in clinical trials evaluating the reactogenicity profile of the vaccine administered subcutaneously either alone or concomitantly with other vaccines. The safety profile presented below is based on a total of 5,369 doses of Varilrix administered alone to infants, children, adolescents and adults. Adverse reactions reported are listed according to the following frequency: Very common: (&ge;1/10) Common: (&ge;1/100 to 39.0&deg;C or rectal temperature &gt; 39.5&deg;C), fatigue, malaise &lowast; According to MedDRA (Medical Dictionary for Regulatory Activities) terminology &dagger; Injection site swelling and pyrexia were reported very commonly in studies conducted in adolescents and adults. Injection site swelling was also reported very commonly after the second dose in children under 13 years of age. A trend for higher incidence of pain, erythema and injection site swelling after the second dose was observed as compared to the first dose. No differences were seen in the reactogenicity profile between initially seropositive and initially seronegative subjects. In a clinical trial, 328 children aged 11 to 21 months received GlaxoSmithKline (GSK)&rsquo;s combined measles, mumps, rubella and varicella vaccine (containing the same varicella strain as Varilrix) either by subcutaneous or intramuscular route. A comparable safety profile was observed for both administration routes. GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics&nbsp; Individuals at high risk of severe varicella There are limited data from clinical trials available in subjects at high risk of severe varicella. However, vaccine-associated reactions (mainly papulo-vesicular eruptions and pyrexia) are usually mild. As in healthy subjects, erythema, swelling and pain at the site of injection are mild and transient Post-marketing data The following additional adverse reactions have been identified in rare occasions during post-marketing surveillance. Because they are reported voluntarily from a population of unknown size, a true estimate of frequency cannot be provided. System organ class&lowast; Adverse reactions Infections and infestations herpes zoster Blood and lymphatic system disorders thrombocytopenia Immune system disorders anaphylactic reaction, hypersensitivity Nervous system disorders encephalitis, cerebrovascular accident, seizure, cerebellitis, cerebellitis like symptoms (including transient gait disturbance and transient ataxia) Vascular disorders vasculitis (including Henoch Schonlein purpura and Kawasaki syndrome) Skin and subcutaneous tissue disorders erythema multiforme &lowast; According to MedDRA (Medical Dictionary for Regulatory Activities) terminology To report any side effect(s): Kingdom of Saudi Arabia -National Pharmacovigilance centre (NPC) &bull; Fax: +966-11-205-7662 &bull; Reporting Hotline:19999 &bull; E-mail: npc.drug@sfda.gov.sa &bull; Website: https://ade.sfda.gov.sa -GlaxoSmithKline - Head Office, Jeddah &bull; Tel: +966-12-6536666 &bull; Mobile: +966-56-904-9882 &bull; Email: saudi.safety@gsk.com &bull; Website: https://gskpro.com/en-sa/ &bull; P.O. Box 55850, Jeddah 21544, Saudi Arabia GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics For any information about this medicinal product, please contact: GlaxoSmithKline - Head Office, Jeddah &bull; Tel: +966-12-6536666 &bull; Mobile: +966-56-904-9882 &bull; Email: gcc.medinfo@gsk.com &bull; Website: https://gskpro.com/en-sa/ &bull; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cases of accidental administration of more than the recommended dose of Varilrix have been reported. Amongst these cases, the following adverse events were reported: lethargy and convulsions. In the other cases reported as overdose there were no associated adverse events.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Pharmacotherapeutic group: Viral vaccines, Varicella zoster vaccines, ATC code J07BK01. Mechanism of action Varilrix produces an attenuated clinically inapparent varicella infection in susceptible subjects. The presence of antibodies is accepted as evidence of protection, however, there is no established limit of protection for varicella disease. Pharmacodynamic effects Efficacy and effectiveness The efficacy of GlaxoSmithKline (GSK)&rsquo;s Oka varicella vaccines in preventing confirmed varicella disease (by Polymerase Chain Reaction (PCR) or exposure to varicella case) has been evaluated in a large randomised multicountry clinical trial, which included GSK&rsquo;s combined measles-mumps-rubella vaccine (Priorix) as active control. The trial has been conducted in Europe where no routine varicella vaccination was implemented at that time. Children aged 12-22 months received one dose of Varilrix or two doses of GSK&rsquo;s combined measles-mumps-rubella-varicella vaccine (Priorix-Tetra) six weeks apart . Vaccine efficacy against confirmed varicella of any severity and against moderate or severe confirmed varicella was observed after a primary follow-up period of 2 years (median duration 3.2 years). Persistent efficacy was observed in the same study during the long term follow-up periods of 6 years GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics (median duration 6.4 years) and 10 years (median duration 9.8 years). The data are presented in the Yable below. Group Timing Efficacy against confirmed varicella of any severity Efficacy against moderate or severe confirmed varicella GSK&rsquo;s monovalent varicella (Oka) vaccine (Varilrix) 1 dose N = 2,487 Year 2 65.4 % (97.5% CI: 57.2; 72.1) 90.7% (97.5% CI: 85.9; 93.9) Year 6(1) 67.0% (95% CI: 61.8; 71.4) 90.3% (95% CI: 86.9; 92.8) Year 10(1) 67.2% (95% CI: 62.3; 71.5) 89.5% (95% CI:86.1; 92.1) GSK&rsquo;s combined measles, mumps, rubella and varicella (Oka) vaccine (Priorix Tetra) 2 doses N = 2,489 Year 2 94.9% (97.5% CI: 92.4; 96.6) 99.5% (97.5% CI: 97.5; 99.9) Year 6(1) 95.0% (95% CI: 93.6; 96.2) 99.0% (95% CI: 97.7; 99.6) Year 10(1) 95.4% (95% CI 94.0; 96.4) 99.1% (95% CI: 97.9; 99.6) N = number of subjects enrolled and vaccinated (1) descriptive analysis In clinical trials, the majority of vaccinated subjects who were subsequently exposed to wild-type virus were either completely protected from clinical chickenpox or developed a milder form of the disease (i.e. low number of vesicles, absence of fever). Effectiveness data, deriving from observation in different contexts (epidemic onset, case-control studies, observational studies, databases, models) suggest a higher level of protection and a decrease in the occurrence of cases of chickenpox following two doses of vaccine compared to a single dose. The impact of one dose of Varilrix in reducing varicella hospitalisations and ambulatory visits among children were respectively 81% and 87% overall. Post-Exposure Prophylaxis Published data on the prevention of varicella following exposure to the varicella virus are limited. In a randomised, double-blind, placebo-controlled study including 42 children aged between 12 months and 13 years, 22 children received one dose of Varilrix and 20 children received one dose of placebo within 3 days after exposure. Similar percentages (41% and 45%, respectively) of children contracted varicella, but the risk of developing a moderate to severe form of the disease was 8 times higher in the GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics placebo group compared with the vaccinated group (relative risk = 8.0; 95% CI: 1.2; 51.5; P=0.003). In a controlled study including 33 children aged between 12 months and 12 years, 15 received varicella vaccine (13 subjects received Varilrix and 2 subjects received another Oka strain varicella vaccine) up to 5 days after exposure and 18 subjects were not vaccinated. When considering the 12 children vaccinated within 3 days after exposure, vaccine effectiveness was 44% (95% CI: -1; 69) in preventing any disease and 77% (95% CI: 14; 94) in preventing moderate or severe disease. In a prospective cohort study (with historic attack rates as control), 67 children, adolescents or adults received varicella vaccine (55 subjects received Varilrix and 12 subjects received another Oka strain varicella vaccine) within 5 days after exposure. Vaccine effectiveness was 62.3% (95% CI: 47.8; 74.9) in preventing any type of disease and 79.4% (95% CI: 66.4; 88.9) in preventing moderate and severe disease. Individuals at high risk of severe varicella Patients suffering from leukaemia, patients under immunosuppressive treatment (including corticosteroid therapy) for malignant solid tumour, for serious chronic diseases (such as chronic renal failure, auto-immune diseases, collagen diseases, severe bronchial asthma) or following organ transplantation, are predisposed to severe natural varicella. Vaccination with the Oka-strain has been shown to reduce the complications of varicella in these patients. Immune response after subcutaneous administration Healthy individuals In children aged 11 months to 21 months the seroresponse rate, when measured by ELISA 6 weeks after vaccination, was 89.6% after one vaccine dose and 100% after the second vaccine dose. In children aged 9 months to 12 years the overall seroconversion rate, when measured by Immunofluorescence Assay (IFA) 6 weeks after vaccination, was &gt;98% after one vaccine dose. In children aged 9 months to 6 years the seroconversion rate, when measured by IFA 6 weeks after vaccination, was 100% after a second vaccine dose. A marked increase of antibody titres was observed following the administration of a second dose (5 to 26-fold increase of geometric mean titres). In subjects aged 13 years and above the seroconversion rate, when measured by IFA 6 weeks after vaccination, was 100% after the second vaccine dose. One year after vaccination, all subjects tested were still seropositive. Individuals at high risk of severe varicella GlaxoSmithKline, Saudi Arabia Summary of Product Characteristics Limited data from clinical trials have shown immunogenicity in subjects at high risk of severe varicella. Immune response after intramuscular administration The immunogenicity of Varilrix administered intramuscularly is based on a comparative study where 283 healthy children aged 11 to 21 months received GSK&rsquo;s combined measles, mumps, rubella and varicella vaccine (containing the same varicella strain as Varilrix) either by subcutaneous or intramuscular route. Comparable immunogenicity was demonstrated for both administration routes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Evaluation of pharmacokinetic properties is not required for vaccines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on general safety tests performed in animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Powder Amino acids (containing phenylalanine) Lactose anhydrous Sorbitol (E 420) Mannitol (E 421) Solvent Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
The expiry date of the vaccine is indicated on the label and packaging. 
After reconstitution, it is recommended that the vaccine be injected as soon as 
possible.
However, it has been demonstrated that the reconstituted vaccine may be kept for up 
to 90 minutes at room temperature (25°C) and up to 8 hours in the refrigerator (2°C to 
8°C). If not used within the recommended in-use storage timeframes and conditions, 

the reconstituted vaccine must be discarded.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store and transport refrigerated (2&deg;C to 8&deg;C). Store in the original package in order to protect from light. For storage conditions after reconstitution of the medicinal product, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Powder in a single-dose glass vial (type I glass) with a stopper (bromobutyl rubber). 0.5 ml of solvent in a pre-filled syringe (type I glass) with plunger stopper (bromobutyl rubber), with or without separate needles in the following pack sizes: - with 1 separate needle: pack sizes of 1 or 10. - with 2 separate needles: pack sizes of 1 or 10. - without needle: pack sizes of 1 or 10. 0.5 ml of solvent in an ampoule (type I glass).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solvent and the reconstituted vaccine should be inspected visually for any foreign particulate matter and/or abnormal physical appearance before administration. In the event of either being observed, do not administer the vaccine. The vaccine must be reconstituted by adding the entire contents of the pre-filled syringe or ampoule of solvent to the vial containing the powder. The vaccine must be reconstituted by adding the entire contents of the pre-filled syringe or ampoule of solvent to the vial containing the powder. To attach the needle to the syringe, carefully read the instructions given with pictures 1 and 2. However, the syringe provided with Varilrix might be slightly different (without screw head) than the syringe illustrated. In that case, the needle should be attached without screwing</p><p>&nbsp;</p><p><u>Instructions for reconstitution of the vaccine with diluent presented in pre-filled syringe</u></p><p><u><img alt="" width="569" height="452" src="data:image/png;base64,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" /></u></p><p>Always hold the syringe by the barrel, not by the syringe plunger or the Luer Lock Adaptor (LLA), and maintain the needle in the axis of the syringe (as illustrated in picture 2). Failure to do this may cause the LLA to become distorted and leak.</p><p>During assembly of the syringe, if the LLA comes off, a new vaccine dose (new syringe and vial) should be used.</p><p>&nbsp;</p><p>1. Unscrew the syringe cap by twisting it anticlockwise (as illustrated in picture 1).</p><p>Whether the LLA is rotating or not, please follow below steps:</p><p>&nbsp;</p><p>2. Attach the needle to the syringe by gently connecting the needle hub into the LLA and rotate a quarter turn clockwise until you feel it lock (as illustrated in picture 2).</p><p>&nbsp;</p><p>3. Remove the needle protector, which may be stiff.</p><p>&nbsp;</p><p>4. Add the diluent to the powder. The mixture should be well shaken until the powder is completely dissolved in the diluent.</p><p>&nbsp;</p><p>After reconstitution, the vaccine should be used promptly.</p><p>&nbsp;</p><p>&nbsp;</p><p>5. Withdraw the entire contents of the vial.</p><p>&nbsp;</p><p>6. A new needle should be used to administer the vaccine. Unscrew the needle from the syringe and attach the injection needle by repeating step 2 above.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p><strong>Varilrix is a trademark owned by or licensed to the GSK group of companies.</strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufacturer:
Version number: UK Issue8draft1 / Date of approval: 
15/10/2021
 2022 GSK group of companies or its licensor
Manufacturer:
GlaxoSmithKline Biologicals s.a.
89, rue de l’Institut - 1330 Rixensart
Belgium
Tel: (32) 2 656 81 11 Fax: (32) 2 656 80 00

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Version number: : UK Issue8draft1 / Date of approval: 15/10/2021
 2022 GSK group of companies or its licensor

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>